D.E. Shaw & Co’s Kyntra Bio KYNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-407
| Closed | -$9.09K | – | 4636 |
|
|
2024
Q2 | $9.09K | Sell |
407
-3,592
| -90% | -$111K | ﹤0.01% | 4319 |
|
|
2024
Q1 | $235K | Sell |
3,999
-70,969
| -95% | -$3.06M | ﹤0.01% | 3852 |
|
|
2023
Q4 | $1.66M | Buy |
74,968
+45,990
| +159% | +$694K | ﹤0.01% | 2818 |
|
|
2023
Q3 | $625K | Buy |
28,978
+27,625
| +2,042% | +$1.08M | ﹤0.01% | 3332 |
|
|
2023
Q2 | $91.3K | Buy |
1,353
+949
| +235% | +$392K | ﹤0.01% | 3836 |
|
|
2023
Q1 | $188K | Buy |
+404
| New | +$214K | ﹤0.01% | 3914 |
|
|
2022
Q4 | – | Sell |
-506
| Closed | -$165K | – | 4929 |
|
|
2022
Q3 | $165K | Buy |
+506
| New | +$163K | ﹤0.01% | 4515 |
|
|
2021
Q3 | – | Sell |
-2,732
| Closed | -$1.82M | – | 5036 |
|
|
2021
Q2 | $1.82M | Buy |
+2,732
| New | +$1.57M | ﹤0.01% | 3034 |
|
|
2020
Q4 | – | Sell |
-1,039
| Closed | -$1.07M | – | 3986 |
|
|
2020
Q3 | $1.07M | Sell |
1,039
-1,690
| -62% | -$1.82M | ﹤0.01% | 2812 |
|
|
2020
Q2 | $2.77M | Buy |
+2,729
| New | +$2.53M | ﹤0.01% | 2141 |
|
|
2020
Q1 | – | Sell |
-654
| Closed | -$701K | – | 4028 |
|
|
2019
Q4 | $701K | Sell |
654
-217
| -25% | -$222K | ﹤0.01% | 3216 |
|
|
2019
Q3 | $805K | Buy |
871
+259
| +42% | +$284K | ﹤0.01% | 2940 |
|
|
2019
Q2 | $691K | Buy |
+612
| New | +$670K | ﹤0.01% | 2901 |
|
|
2019
Q1 | – | Sell |
-6,547
| Closed | -$7.58M | – | 3695 |
|
|
2018
Q4 | $7.58M | Buy |
6,547
+6,295
| +2,498% | +$7.08M | 0.01% | 1263 |
|
|
2018
Q3 | $382K | Buy |
+252
| New | +$388K | ﹤0.01% | 3251 |
|
|
2017
Q4 | – | Sell |
-954
| Closed | -$1.28M | – | 3609 |
|
|
2017
Q3 | $1.28M | Sell |
954
-104
| -10% | -$110K | ﹤0.01% | 2334 |
|
|
2017
Q2 | $854K | Sell |
1,058
-313
| -23% | -$218K | ﹤0.01% | 2507 |
|
|
2017
Q1 | $845K | Sell |
1,371
-1,942
| -59% | -$1.18M | ﹤0.01% | 2413 |
|
|
2016
Q4 | $1.77M | Buy |
3,313
+476
| +17% | +$238K | ﹤0.01% | 2076 |
|
|
2016
Q3 | $1.47M | Sell |
2,837
-655
| -19% | -$309K | ﹤0.01% | 2134 |
|
|
2016
Q2 | $1.43M | Sell |
3,492
-959
| -22% | -$439K | ﹤0.01% | 2170 |
|
|
2016
Q1 | $2.37M | Sell |
4,451
-5,365
| -55% | -$2.67M | ﹤0.01% | 1767 |
|
|
2015
Q4 | $7.48M | Buy |
9,816
+2,115
| +27% | +$1.4M | 0.01% | 1143 |
|
|
2015
Q3 | $4.22M | Buy |
7,701
+1,172
| +18% | +$710K | 0.01% | 1522 |
|
|
2015
Q2 | $3.84M | Buy |
+6,529
| New | +$3.8M | 0.01% | 1673 |
|
|
2015
Q1 | – | Sell |
-659
| Closed | -$450K | – | 3739 |
|
|
2014
Q4 | $450K | Buy |
+659
| New | +$424K | ﹤0.01% | 3407 |
|
Other funds holding KYNB
AC
6CM
GC
D.E. Shaw & Co's KYNB Position: Q3 2024 in Review
D.E. Shaw & Co sold out of Kyntra Bio (KYNB) in Q3 2024, closing a stake of 407 shares — an estimated $9.09K sold.
D.E. Shaw & Co first reported a position in KYNB in Q4 2014 and held it in 26 quarters. The position peaked at $7.58M in Q4 2018. 70 funds tracked by Wall St. Rank hold KYNB as of Q3 2024.
- D.E. Shaw & Co reported no remaining Kyntra Bio position as of Q3 2024 after selling out during the quarter.
- D.E. Shaw & Co sold 407 Kyntra Bio shares in Q3 2024, an estimated $9.09K.
- D.E. Shaw & Co first reported a position in Kyntra Bio in Q4 2014 and held it in 26 quarters.
- D.E. Shaw & Co's Kyntra Bio position peaked at $7.58M in Q4 2018.
- 70 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2024.
Based on D.E. Shaw & Co's 13F filing for Q3 2024, filed 14 Nov 2024.